Modelling The Costs and Outcomes Associated With Sequence Of Treatment With And Without Tofacitinib For The Treatment of Moderate to Severe Rheumatoid Arthritis In The Us

May 1, 2015, 00:00
10.1016/j.jval.2015.03.932
https://www.valueinhealthjournal.com/article/S1098-3015(15)00989-4/fulltext
Title : Modelling The Costs and Outcomes Associated With Sequence Of Treatment With And Without Tofacitinib For The Treatment of Moderate to Severe Rheumatoid Arthritis In The Us
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00989-4&doi=10.1016/j.jval.2015.03.932
First page : A161
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 383
Categories :
Tags :
Regions :
ViH Article Tags :